GDC-0941
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for GDC-0941, covering 2016-11-02 to 2017-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast Cancer [Phase 2]